Human IgG antibody Laboratories manufactures the dr. martens spikes reagents distributed by Genprice. The Dr. Martens Spikes reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S. Other Dr. products are available in stock. Specificity: Dr. Category: Martens Group: Spikes
Human True insulin ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True Insulin GENLISA ELISA |
Krishgen |
1 x 96 wells |
EUR 286 |
Human True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Spikes information
SARS Spike (1-666) |
sars-025 |
ProSpec Tany |
50µg |
EUR 900 |
Description: Recombinant SARS Associated Coronavirus Spike (1-666 a.a.) |
SARS Spike (14-667) |
sars-031 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant SARS Associated Coronavirus Spike (14-667 a.a.) |
SARS Spike (306-527) |
sars-032 |
ProSpec Tany |
50µg |
EUR 900 |
Description: Recombinant SARS Associated Coronavirus Spike Receptor Binding Domain (306-527 a.a.) |
CoV-2 Spike (1-1211) |
sars-041 |
ProSpec Tany |
50µg |
EUR 900 |
Description: Recombinant Coronavirus 2019 Spike (1-1211 a.a. ) |
SARS Spike (306-515) |
sars-046 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant SARS Associated Coronavirus Spike Receptor Binding Domain (306-515 a.a.) |
SARS Spike (14-1195) |
sars-048 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant SARS Associated Coronavirus Spike (14-1195 a.a.) |
CoV-2 Spike (318-542) |
sars-057 |
ProSpec Tany |
100µg |
EUR 200 |
Description: Recombinant Coronavirus 2019 Spike Receptor Binding Domain (318-542 a.a.) |
SARS Spike (306-515), Sf9 |
sars-047 |
ProSpec Tany |
2µg |
EUR 60 |
Description: Recombinant SARS Associated Coronavirus Spike Receptor Binding Domain (306-515 a.a.), Sf9 |
Spike S1 (16-685), Fc fusion (SARS-CoV-2) |
100688-1 |
BPS Bioscience |
20 µg |
EUR 405 |
Description: SARS-CoV-2 2019-nCoV Spike protein S1, also known as SARS-CoV s1 and coronavirus spike S1, GenBank Accession No. QHD43416.1, a.a. 16-685, with C-terminal Fc-tag, expressed in a CHO cell expression system. MW= 160 kDa. |
Spike S1 (16-685), Avi-His-tag (SARS-CoV-2) |
100730-1 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685 with a C-terminal Avi-His-tag, expressed in a HEK293 expression system, MW=78 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Spike S1 (16-685), Avi-His-tag (SARS-CoV-2) |
100730-2 |
BPS Bioscience |
1 mg |
EUR 2720 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685 with a C-terminal Avi-His-tag, expressed in a HEK293 expression system, MW=78 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Spike S1 (13-665), Fc Fusion, Avi-tag (SARS-CoV-2) |
100678-1 |
BPS Bioscience |
100 µg |
EUR 350 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 13-665, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=102 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Spike S1 (13-665), Fc Fusion, Avi-tag (SARS-CoV-2) |
100678-2 |
BPS Bioscience |
1 mg |
EUR 3000 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 13-665, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=102 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2) |
100719-1 |
BPS Bioscience |
100 µg |
EUR 320 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=104 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
Spike S1 (16-685), Fc Fusion, Avi-tag (SARS-CoV-2) |
100719-2 |
BPS Bioscience |
1 mg |
EUR 2720 |
Description: Severe acute respiratory Coronavirus 2 Spike Glycoprotein S1 (SARS-CoV-2 Spike S1), GenBank Accession No. QHD43416.1, a.a. 16-685, fused at the C-terminus of the Fc portion of human IgG1, with a C-terminal Avi-tag™, expressed in a HEK293 expression system, MW=104 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation. |
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag |
E80021 |
EpiGentek |
|
|
SARS-CoV-2 (COVID-19) Spike 156-157EF Antibody |
9685-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: SARS-CoV-2 delta variant, a variant of concern (VOC), known as B.1.617.2, was detected in India in October of 2020. However, it rapidly spread all over of the world and now it is the dominant variant in the world, which account for more than 99% of the cases. This variant carries at least 13 mutations in spike protein across the sub lineages, including L452R, D614G, P681R and K417N, which can increase the affinity to the human ACE2 receptor. Enhanced transmission of the Delta variant was observed globally, which is at least 2.5 times more contagious as the other variants. The Delta variant affects the effectiveness of COVID19 vaccine and is resistant to neutralization to some extent. |